IL-23 promotes neuronal ferroptosis via IL-23R/STAT3 signaling after traumatic brain injury by Bo Chen, Guihong Shi, Jianye Xu, Xu Zhang, Yanlin Zhu, Lei Li, Cong Wang, Dilmurat Gheyret, Jinchao Wang, Xilei Liu, Yiyao Cao, Rui Tan, Yuan Zhou, RongCai Jiang, Shenghui Li, Tuo Li, Xiao Liu, Xin Chen, Guili Yang, Jianning Zhang, Shu Zhang

Subjects: “…IL-23/IL-23R signaling…”
Get full text

Real-World Study of Tildrakizumab Survival in Psoriasis: Impact of Arthritis, Hypertension, and Prior Biologic Use by Raquel Santos-Juanes Galache, Sebastian Reyes García, Jimena Carrero Martín, Álvaro Nuñez Domínguez, Marta López Pando, Irene Álvarez Losada, Irene de la Fuente Villaverde, Ana Lozano-Blazquez, Esther Salgueiro, Javier Bordallo, Jorge Santos-Juanes, Cristina Galache Osuna

Subjects: Get full text

Commentary: Guselkumab binding to CD64+ IL-23–producing myeloid cells enhances potency for neutralizing IL-23 signaling by Giulia Valdiserra, Clelia Di Salvo, Matteo Fornai, Luca Antonioli

Subjects: “…IL-23…”
Get full text

Assessment of The Impact of Apremilast on Levels of IL-17, IL-23, and Lipids in Obese Psoriatic Patient by Haitham M. Saad, Adil A. Noaimi, Halla Gh. Mahmood

Subjects: Get full text

Xuetongsu attenuates synovial inflammation in rheumatoid arthritis by inhibiting the IL-23/IL-17/NF-κB inflammatory axis by Yuxin Chen, Yasi Deng, Hao Zheng, Hao Zheng, Bin Li, Yupei Yang, Juan Huang, Hanwen Yuan, Mengyun Wang, Wei Wang, Huanghe Yu

Subjects: Get full text

Features of interleukin-17 and interleukin-23 expression in patients with inflammatory bowel diseases by Yu.M. Stepanov, M.V. Stoikevych, O.M. Tatarchuk, T.S. Tarasova

Subjects: Get full text

Efficacy and safety of Mirikizumab for ulcerative colitis: a systematic review and meta-analysis of randomized controlled trials by Mohamed A. Abu Elainein, Sama S. ElSherefy, Norhan M. Yousef, Sama M. ElKady, Nada G. Hamam, Abdullrahman Elgarawany, Darin W. Aswa, Ahmed Nour Eldin Hassan, Salma Allam

Subjects: Get full text

DIFFERENCES IN INTERLEUKIN-23 SERUM LEVELS TOWARDS THE SEVERITY OF ACNE VULGARIS IN WOMEN by Wafi Banadzir Resya, Novi Kusumaningrum, Santoso Jaeri, Astika Widy Utomo

Subjects: “…il-23, acne vulgaris, grade of acne vulgaris severity.…”
Get full text

Off-label dermatologic uses of IL-23 inhibitors by Justin Porter, Lacey Zimmerman, Melissa Nickles, Sheryl Hoyer

Subjects: Get full text

Optimizing Tildrakizumab Dosing in Psoriasis: A 52-Week Multicenter Retrospective Study Comparing 100 mg and 200 mg—IL PSO (Italian Landscape Psoriasis) by Mario Valenti, Luciano Ibba, Sara Di Giulio, Luigi Gargiulo, Piergiorgio Malagoli, Anna Balato, Federico Bardazzi, Francesco Loconsole, Martina Burlando, Anna E. Cagni, Norma Cameli, Carlo G. Carrera, Andrea Carugno, Aldo Cuccia, Paolo Dapavo, Eugenia V. Di Brizzi, Valentina Dini, Maria C. Fargnoli, Francesca M. Gaiani, Claudio Guarneri, Claudia Lasagni, Gaetano Licata, Angelo V. Marzano, Matteo Megna, Santo R. Mercuri, Alessandra Michelucci, Maria L. Musumeci, Diego Orsini, Romina Ortega, Luca Potestio, Luca Rapparini, Simone Ribero, Francesca Satolli, Davide Strippoli, Emanuele Trovato, Marina Venturini, Leonardo Zichichi, Pina Brianti, Antonio Costanzo, Alessandra Narcisi

Subjects: “…Anti-IL-23…”
Get full text

Interleukin biomarkers as predictive tools for lupus nephritis grade and disease activity in systemic lupus erythematosus by Dalia S. Saif, shimaa Abdelsattar, Enas S. Zahran, Mohammed Khalil, Sanaa Samir, Hend E. Abo Mansour

Subjects: Get full text

Effectiveness of tildrakizumab 200 mg: an Italian multicenter study by Annunziata Dattola, Nicoletta Bernardini, Francesca Svara, Anna Balato, Giacomo Caldarola, Domenico D’Amico, Clara De Simone, Eugenia Veronica Di Brizzi, Maria Esposito, Claudia Giofrè, Domenico Giordano, Claudio Guarneri, Francesco Loconsole, Viviana Lora, Gaia Moretta, Diego Orsini, Severino Persechino, Concetta Potenza, Simone Ragonesi, Giovanni Pellacani, Ketty Peris, Maria Concetta Fargnoli, Antonio Giovanni Richetta

Subjects: Get full text

IL-12 family cytokines and autoimmune diseases: A potential therapeutic target? by Xiaoyu Cui, Wu Liu, Hanxue Jiang, Qihan Zhao, Yuehong Hu, Xinyue Tang, Xianli Liu, Haoran Dai, Hongliang Rui, Baoli Liu

Subjects: Get full text

Genetic Variants of the IL‐23/IL‐17 Axis and Its Association With Periodontal Disease: A Systematic Review by Ruth Rodríguez‐Montaño, Mario Alberto Alarcón‐Sánchez, Sarah Monserrat Lomelí‐Martínez, Cristina Hermila Martínez‐Bugarin, Artak Heboyan

Subjects: Get full text

Ustekinumab Biosimilars by Elena Carmona-Rocha, Lluís Puig

Subjects: Get full text

Translational Pharmacokinetics of Icotrokinra, a Targeted Oral Peptide that Selectively Blocks Interleukin-23 Receptor and Inhibits Signaling by Beverly Knight, Brinda Tammara, Nishit B. Modi, Shannon Dallas, Saro Mardirosian, Jianyao Wang, Aline Laenen, Laurent Leclercq, Karen DiLoreto, Lieve Adriaenssen, Darren Moss, David Polidori, Siladitya Ray Chaudhuri, Seonghee Park, Carlo Sensenhauser, Anthony Ndifor, Siddharth Sukumaran, Tristan Baguet, Yifan Shi, Shefali Patel, Brian Geist, Anne Fourie, Raymond Patch, Chengzao Sun, Stephanie A. Barros, Sandeep Somani, Mario Monshouwer

Subjects: Get full text

Distinct Impact of Phosphodiesterade-4 (PDE4) Inhibition in Two Pre-clinical Psoriasis Models by Sören Dräger, Thorge Mester, Hermann Tenor, Ralf J. Ludwig, Katja Bieber

Subjects: Get full text

Successful treatment of generalized pustular psoriasis with guselkumab by Martina Part

Subjects: Get full text

Positioning Guselkumab in The Treatment Algorithm of Patients with Crohn’s Disease by D'Amico F, Bencardino S, Magro F, Dignass A, Gutiérrez Casbas A, Verstockt B, Hart A, Armuzzi A, Peyrin-Biroulet L, Danese S

Subjects: Get full text

Interleukin-23p19 inhibitors for the treatment of moderate-to-severe psoriasis: an expert opinion of real-world evidence studies in Europe by S. Ständer, D. Thaçi

Subjects: “…Anti-IL-23p19…”
Get full text